It's Not Just Hot Flashes: The Perimenopause Symptoms No One Warned You About

Frozen shoulder. Joint pain. Heart palpitations. Itchy skin. A burning tongue. Rage that arrives at 3 a.m. and won’t leave. If you’ve typed any of those into Google with the words “am I going crazy” attached, this article is for you. You are not crazy. You may be perimenopausal — and most of the symptoms on this list weren’t covered in your annual.

For a long time, the public conversation about perimenopause was two symptoms: hot flashes and missed periods. The clinical reality is much wider. More than 30 symptoms are routinely catalogued, and the count keeps growing. What’s changed in the last two years isn’t the biology — it’s the willingness to name it.

Below is the field guide we wish every woman in her 40s had on her phone — grouped by what most women expect, what catches them off guard, and what’s most often misdiagnosed. Because not everything in this window is hormonal, even when it looks that way.

Perimenopause is the transition leading up to menopause: the years during which ovarian hormone production becomes erratic before stopping. According to The Menopause Society, it typically begins in a woman’s mid-40s and lasts an average of about 4 years, though for many women it stretches 8 to 10 years. Menopause itself — defined as 12 consecutive months without a period — occurs in the U.S. at an average age of 52.

The defining feature of perimenopause is variability. Estrogen doesn’t drop in a steady line; it surges and crashes, sometimes higher than premenopausal levels, sometimes much lower, often within the same cycle. Progesterone usually declines earlier and more linearly. That hormonal turbulence is why symptoms come and go, change month to month, and feel maddeningly inconsistent. A clinician who tells you “your labs are normal, so this isn’t perimenopause” may be reading a single snapshot of a hormone that is, by definition, fluctuating.

The “34 symptoms of perimenopause” framework you’ve seen on Instagram is not a single peer-reviewed list — it’s a popular educational tally that’s grown over time. Some clinicians count 30, others 40 or more. The exact number matters less than the principle: estrogen receptors are present in nearly every tissue in the body, which is why hormone shifts can produce symptoms almost anywhere — bones, skin, gut, brain, joints, bladder, eyes, gums, even tongue.

These have made it into the cultural script. They’re real, common, and worth treating — but they’re not the whole story.

• Hot flashes and night sweats (vasomotor symptoms): affect roughly 75–80% of women at some point in the transition.
• Irregular periods: cycles get longer, shorter, heavier, or lighter — often all in the same year.
• Sleep disturbance: trouble falling asleep, but more often waking at 2 or 3 a.m. and not getting back down.
• Mood changes: irritability, anxiety, tearfulness, often premenstrually amplified. Perimenopausal women have roughly a 40% higher risk of depressive symptoms than premenopausal women.
• Vaginal dryness and reduced libido: about a third of women aged 35–54 report vaginal dryness; nearly half report reduced libido.

If you’re checking boxes here, none of it is in your head. These are the symptoms hormone therapy was originally approved to treat.

This is the cluster that drives most of the “wait, is that perimenopause too?” recognition. Each has a plausible mechanism tied to fluctuating estrogen and is increasingly cited in modern menopause reviews.

• Joint pain (menopausal arthralgia). A 2024 review in Climacteric — “The musculoskeletal syndrome of menopause” — estimates more than 70% of women experience musculoskeletal symptoms during the transition, with about 25% significantly disabled. Estrogen has anti-inflammatory effects on synovial tissue; its loss appears to unmask or worsen joint aches that didn’t exist before.

• Frozen shoulder (adhesive capsulitis). Three-quarters of frozen shoulder patients are women, with peak incidence between ages 40 and 60 — the perimenopausal window. A 2025 Journal of Clinical Medicine review proposes frozen shoulder as a systemic immunometabolic disorder in which declining estrogen contributes to capsular fibrosis. Observational data cited in the literature suggest women on hormone therapy have roughly half the frozen shoulder rate of women not on HRT, and a UCSF trial is currently testing whether HRT speeds recovery. If you wake up one morning unable to reach behind your back and you’re 47, hormones are a reasonable line of inquiry.

• Heart palpitations. A fluttering, skipped-beat, or pounding sensation, often at rest. Common during hormonal shifts and usually benign once cardiac causes are ruled out — but should be evaluated.

• Migraines or worsening headaches. Particularly in women with a history of menstrual migraine, perimenopausal estrogen swings can intensify or change the pattern.

• Itchy skin, dry skin, and “formication” (the sensation of insects crawling on the skin). Estrogen supports skin hydration and barrier function; its loss shows up here.

• Dry eyes. Estrogen affects the lacrimal glands; many women find their contact lenses suddenly intolerable in their late 40s.

• Burning mouth or tongue. Burning mouth syndrome has a striking female predominance peaking in midlife.

• Tinnitus, gum sensitivity, central-fat redistribution, and new histamine reactions (hives, flushing, food sensitivities) round out the list — each with a plausible link to estrogen receptor activity in the affected tissue.

This is the cluster that gets the “I thought it was just me” reaction. Often, it isn’t.

The hardest category. These send women through cardiology, neurology, psychiatry, rheumatology, and ENT before anyone says the word “perimenopause.”

• Brain fog. Memory lapses, word-finding difficulty, trouble multitasking. In a 2024 PET imaging study from Weill Cornell, Dr. Lisa Mosconi and colleagues showed that estrogen receptor density in the brain — particularly in the hippocampus and prefrontal cortex — increases as women transition through menopause and remains elevated into the mid-60s. Higher ER density in those regions correlated with worse self-reported cognitive symptoms. This is mechanism, not mysticism. Cognitive symptoms in perimenopause are most often not a sign of early dementia, and they frequently improve when sleep and hot flashes are addressed.

• Anxiety that looks like a new diagnosis. Onset in the mid-40s without prior history, often described as “a low-grade panic I can’t explain.” Frequently labeled generalized anxiety before the hormonal pattern is recognized.

• Depression that doesn’t respond as expected to SSRIs. Sometimes the answer is hormones, sometimes it’s hormones and an antidepressant, sometimes it’s an antidepressant alone. The diagnostic mistake is assuming it must be one or the other.

• ADHD that “suddenly appeared” at 45. Estrogen modulates dopamine, and falling estrogen may unmask attentional vulnerability that was previously compensated. Many women describe worsening attentional symptoms in perimenopause; some receive a first-time ADHD diagnosis in their 40s.

• Insomnia treated as primary insomnia. Sleep-clinic workups that don’t ask about cycle changes can miss the hormonal driver entirely.

• Recurrent UTIs, urinary urgency, and pelvic pain. Genitourinary syndrome of menopause (GSM) shows up at the doctor’s office as one bladder infection after another. Local vaginal estrogen is the standard, well-supported treatment — and most women have never been offered it.

• Hair changes. Thinning at the part line, more shedding in the shower, and sometimes new hair on the chin or jawline as estrogen drops relative to androgens.

The point of this list is not that every symptom is “just” perimenopause. It’s that perimenopause should be on the differential — and frequently isn’t.

There are structural reasons these symptoms get sorted into the wrong specialty.

Timing is part of it. Perimenopause can begin 8 to 10 years before the final menstrual period — but the cultural script puts menopause in the 50s, so a symptomatic 44-year-old with regular cycles is rarely on the menopause differential. A single FSH or estradiol can read normal during active perimenopause because the fluctuation is the diagnosis. The training gap matters too: surveys of U.S. OB-GYN residencies have repeatedly found that fewer than a third provide structured menopause education. And the symptom catalogue is wide — when a primary-care visit is 12 minutes and a patient presents with a frozen shoulder and trouble sleeping, the conversation goes to orthopedics and melatonin. The connective thread (“you’re 46 and your cycles have shortened by a week”) has to be actively pulled out, and often isn’t.

The most useful thing a clinician can do for a perimenopausal woman is not, in our experience, to immediately start hormones. It’s to listen long enough to see the pattern, then test what’s actually testable.

A reasonable workup includes a 12–24 month symptom and cycle history (the diagnosis is largely clinical) and baseline labs that look at the whole picture, not just sex hormones — TSH, CBC, ferritin, comprehensive metabolic panel, lipids, vitamin D, sometimes B12. Many of perimenopause’s signature symptoms — fatigue, brain fog, mood, joint pain, hair changes — also belong to thyroid disease, iron deficiency, vitamin D deficiency, and undiagnosed sleep apnea. Treating perimenopause without checking for these is a missed opportunity. Cardiovascular and bone-health screening anchored to individual risk belongs in the same visit.

From there, the plan branches. Sometimes the answer is hormone therapy — for women within the 10-year window from final menstrual period and under age 60, the FDA’s 2026 label change reflects evidence that MHT is a reasonable option for symptomatic women. Sometimes the answer is targeted non-hormonal prescription — an SSRI or SNRI for vasomotor symptoms or mood, gabapentin for sleep, fezolinetant for hot flashes, vaginal estrogen for urinary symptoms. Sometimes the answer is structural — strength training, protein-forward eating, sleep hygiene that fits midlife biology, and a hard look at alcohol. Often it’s some combination of all three.

What a careful clinic refuses to do is reduce every midlife symptom to “it’s all hormones.” Estrogen explains a lot. It does not explain everything. The job of the consult is to figure out which is which.

At Naya Wellness, the BHRT consult is built to function as a symptom decoder, not a hormone vending machine. The first visit is a long conversation — cycle history, symptom inventory, family history, medications, sleep, lifestyle, what’s been tried and what hasn’t. Labs are drawn based on what the conversation surfaces, not a one-size template. The treatment plan that follows might include hormone therapy — bioidentical estradiol, oral micronized progesterone, sometimes low-dose testosterone — or it might not.

Carolyn Pampalone, MSN, FNP-BC, has spent nearly two decades in women’s health and hormone care. If you’ve been bouncing between specialists, or you’ve been told your labs are “normal” while you feel like a stranger in your own body, that’s exactly the kind of conversation we have at Naya — at our Chatsworth or Santa Barbara clinics, or by telehealth across California.

Two California locations and statewide telehealth — click a card to view details, or call to schedule a consult.